Virologic Tools for HCV Drug Resistance Testing

Recent advances in molecular biology have led to the development of new antiviral drugs that target specific steps of the Hepatitis C Virus (HCV) lifecycle. These drugs, collectively termed direct-acting antivirals (DAAs), include non-structural (NS) HCV protein inhibitors, NS3/4A protease inhibitor...

Full description

Bibliographic Details
Main Authors: Slim Fourati, Jean-Michel Pawlotsky
Format: Article
Language:English
Published: MDPI AG 2015-12-01
Series:Viruses
Subjects:
Online Access:http://www.mdpi.com/1999-4915/7/12/2941